NCT05393765

Brief Summary

This study aimed to investigate the effect of an interactive web-based program that supports nurse-led self-regulation in the management of Multiple Sclerosis (MS) on the self-management, fatigue and anxiety levels of patients with Multiple Sclerosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 26, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

June 13, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

May 20, 2022

Last Update Submit

September 11, 2023

Conditions

Keywords

Multiple SclerosisSelf-ManagementNursingSelf-Regulation

Outcome Measures

Primary Outcomes (1)

  • Change in self-management

    The Multiple Sclerosis Self-Management Scale (MSSM) will be used to assess self-management knowledge and behavior of individuals with MS comprehensively and psychometrically. The MSSM consists of 24 Likert-type items with re-sponses as follows: disagree completely (1 point), somewhat disagree (2 points), neither agree nor dis-agree (3 points), somewhat agree (4 points), and agreecompletely (5 points). The MSSM includes 5 subscales: healthcare providerrelationship/communication, treatment adherence/barriers, social/family support, MS knowledge and information, and health maintenance behavior. Total score ranges between 0 and 100, and a higherscore indicates a higher degree of self-management.

    Baseline and 8 weeks after patient inclusion

Secondary Outcomes (4)

  • Fatigue Severity Scale

    Baseline and 8 weeks after patient inclusion

  • State-Trait Anxiety Inventory (STAI)

    Baseline and 8 weeks after patient inclusion

  • System Usability Scale

    8 weeks after patient inclusion

  • Program Usage Level Tracking Form

    8 weeks after patient inclusion

Study Arms (2)

experimental

EXPERIMENTAL

Experimental: Intervention group "Yönetebilirim" Before the initiation of the program, patients who visit the outpatient clinic will be evaluated according to the inclusion-exclusion criteria, their consent will be obtained, and pre-tests will be administered. Then, randomization will be performed and participants will be assigned to the experimental and control groups. Participants in the experimental group will be registered on the web-based program. The individuals in the experimental group will use "Yönetebilirim" for 8 weeks as of the time the program is put into use. "Yönetebilirim" consists of modules and consultancy services. Participants will be able to watch informative videos as much as they want for 8 weeks and receive consultancy service if they wish.

Behavioral: Yönetebilirim

Control

NO INTERVENTION

The control group will receive standard care without any intervention. The group will not receive any other intervention.

Interventions

YönetebilirimBEHAVIORAL

"Yönetebilirim" is an interactive web-based program developed to improve the self-management skills of individuals with MS by supporting self-regulation under the leadership of nurses.

experimental

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be diagnosed with Multiple Sclerosis,
  • Expanded Disability Status Scale (EDSS) score below 5,
  • Be in the 7-12 age range18-65,
  • Having the ability to read and write,
  • To be able to communicate in Turkish
  • Being able to access and use the Internet (computer, tablet, mobile phone)

You may not qualify if:

  • To have received steroid treatment for an attack in the last month
  • Having a psychiatric diagnosis (schizophrenia, bipolar affective disorder etc.)
  • Having advanced cognitive problems
  • Being visually and hearing impaired.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Selçuklu, Konya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple SclerosisSelf-Control

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSocial BehaviorBehavior

Study Officials

  • Selda Arslan, Phd

    Necmettin Erbakan University Faculty of Nursing

    STUDY DIRECTOR
  • Ayyüce Tuba Koçak, MSC

    Selcuk University Faculty of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized controlled trial with a two-group pre-test and post-test design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research assistant

Study Record Dates

First Submitted

May 20, 2022

First Posted

May 26, 2022

Study Start

June 13, 2022

Primary Completion

September 1, 2022

Study Completion

June 1, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
3 mounts later

Locations